Home / Science / Tech CEO Uses AI to Save Dying Dog's Life
Tech CEO Uses AI to Save Dying Dog's Life
15 Mar
Summary
- An AI-created vaccine targeted specific tumor mutations in Rosie's cancer.
- Rosie, diagnosed with mast cell cancer, showed significant improvement after treatment.
- The innovative treatment faced regulatory hurdles but may pave way for new therapies.
A tech entrepreneur has leveraged artificial intelligence and ChatGPT to create a custom cancer vaccine for his rescue dog, Rosie. Rosie, an eight-year-old dog, was diagnosed with mast cell cancer and faced a grim prognosis of only months to live. Traditional treatments proved ineffective against the growing tumors.
With expertise in machine learning, the entrepreneur utilized AI tools, including AlphaFold for protein structure analysis, to design an mRNA vaccine. This vaccine was specifically engineered to target mutations found in Rosie's tumor DNA. The treatment was developed in collaboration with researchers from the University of New South Wales and administered in December.
Following the vaccination, Rosie has demonstrated remarkable improvement. Her tumor has reportedly halved in size, and her energy levels have significantly increased, allowing her to engage in activities she previously couldn't. While not considered a definitive cure, this AI-driven approach has seemingly provided Rosie with substantially more time and enhanced quality of life. The process involved obtaining ethics approval, which took three months, highlighting the innovative yet challenging path of AI in personalized medicine.
